Allarity Therapeutics Inc (ALLR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,352 | -16,058 | -13,220 | -8,183 | -3,080 |
| Depreciation Amortization | 10 | 17,631 | 14,065 | 14,054 | 14,030 |
| Income taxes - deferred | 0 | -1,612 | -1,342 | -1,223 | -1,227 |
| Accounts payable and accrued liabilities | 198 | 6,207 | 4,483 | 5,175 | 5,036 |
| Other Working Capital | 571 | -328 | -1,259 | -1,857 | -2,514 |
| Other Operating Activity | -628 | -22,657 | -17,098 | -17,929 | -18,000 |
| Operating Cash Flow | $-3,201 | $-16,817 | $-14,371 | $-9,963 | $-5,755 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -18 | N/A | N/A | N/A |
| Net Acquisitions | N/A | 809 | 809 | 809 | 809 |
| Investing Cash Flow | $N/A | $791 | $809 | $809 | $809 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,000 | N/A | N/A | N/A |
| Other Financing Activity | 1,158 | -2,311 | -2,311 | -2,311 | 0 |
| Financing Cash Flow | $1,158 | $-1,311 | $-2,311 | $-2,311 | $N/A |
| Exchange Rate Effect | 309 | -189 | 264 | -413 | -65 |
| Beginning Cash Position | 2,029 | 19,555 | 19,555 | 19,555 | 19,555 |
| End Cash Position | 295 | 2,029 | 3,946 | 7,677 | 14,544 |
| Net Cash Flow | $-1,734 | $-17,526 | $-15,609 | $-11,878 | $-5,011 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,201 | -16,817 | -14,371 | -9,963 | -5,755 |
| Capital Expenditure | N/A | -18 | N/A | N/A | N/A |
| Free Cash Flow | -3,201 | -16,835 | -14,371 | -9,963 | -5,755 |